The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The impact of portability of wearable monitoring device on study retention and participant experience in patients with unresectable stage III NSCLC treated with standard-of-care durvalumab: Learnings from the ON TRAX pilot study.
 
Ion Cotarla
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
Consulting or Advisory Role - Gerson Lehrman Group; ISR reports; M3
 
Nicole Zahradka
Employment - Current Health
Stock and Other Ownership Interests - Best Buy
 
Omoruyi Credit Irabor
Employment - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca
 
Lance Brannman
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca; Biodesix; Medtronic; Sonic Healthcare
Travel, Accommodations, Expenses - AstraZeneca
 
Aditya Bhosale
Employment - Current Health
Stock and Other Ownership Interests - Best Buy Health
 
Amanda Coldiron
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Karen Murphy
Employment - AstraZeneca; AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Matt Wilkes
Employment - Current Health
Stock and Other Ownership Interests - Best Buy
Travel, Accommodations, Expenses - Current Health
 
Jhanelle Elaine Gray
Honoraria - Jazz Pharmaceuticals; Merck; OncoCyte
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca/MedImmune; Blueprint Medicines; Blueprint Medicines; Blueprint Medicines; Bristol Myers Squibb; EMD Serono; Janssen Scientific Affairs; Jazz Pharmaceuticals; Lilly; Loxo; Merck Sharp & Dohme; National Comprehensive Cancer Network; Novartis; Sanofi
Research Funding - Array BioPharma (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); ECOG-ACRIN (Inst); G1 Therapeutics (Inst); Genentech/Roche (Inst); Ludwig Institute for Cancer Research (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); SWOG (Inst)
Travel, Accommodations, Expenses - Novartis; OncoCyte